Panagora Asset Management Inc Macrogenics Inc Transaction History

Panagora Asset Management Inc

$21 Billion
Q4 2024

A detailed history of Panagora Asset Management Inc transactions in Macrogenics Inc stock. As of the latest transaction made, Panagora Asset Management Inc holds 255,745 shares of MGNX stock, worth $718,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares

255,745

Previous 354,835 27.93%

Holding current value

$718,643

Previous $1.17 Million 28.79%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$3.18 - $4.46 $315,106 - $441,941	-99,090 Reduced 27.93%	255,745 $831,000
Q3 2024 Nov 13, 2024	SELL	$3.0 - $5.55 $1.16 Million - $2.15 Million	-386,655 Reduced 52.15%	354,835 $1.17 Million
Q2 2024 Jul 29, 2024	BUY	$3.31 - $18.51 $920,378 - $5.15 Million	278,060 Added 60.0%	741,490 $3.15 Million
Q1 2024 May 07, 2024	BUY	$9.77 - $21.47 $630,028 - $1.38 Million	64,486 Added 16.16%	463,430 $6.82 Million
Q4 2023 Feb 08, 2024	BUY	$4.48 - $10.11 $90,872 - $205,071	20,284 Added 5.36%	398,944 $3.84 Million
Q3 2023 Oct 31, 2023	SELL	$4.48 - $6.19 $21,571 - $29,804	-4,815 Reduced 1.26%	378,660 $1.76 Million
Q2 2023 Aug 11, 2023	BUY	$4.62 - $7.54 $2,199 - $3,589	476 Added 0.12%	383,475 $2.05 Million
Q1 2023 May 11, 2023	BUY	$4.82 - $7.24 $421,369 - $632,928	87,421 Added 29.58%	382,999 $2.75 Million
Q4 2022 Feb 13, 2023	BUY	$3.34 - $6.98 $197,250 - $412,217	59,057 Added 24.97%	295,578 $1.98 Million
Q3 2022 Nov 14, 2022	SELL	$3.01 - $5.22 $144,696 - $250,935	-48,072 Reduced 16.89%	236,521 $818,000
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $90,830 - $403,286	40,369 Added 16.53%	284,593 $840,000
Q1 2022 May 12, 2022	BUY	$8.12 - $16.9 $654,504 - $1.36 Million	80,604 Added 49.26%	244,224 $2.15 Million
Q4 2021 Feb 10, 2022	BUY	$15.91 - $21.88 $915,986 - $1.26 Million	57,573 Added 54.29%	163,620 $2.63 Million
Q3 2021 Nov 10, 2021	SELL	$19.74 - $28.7 $2.47 Million - $3.59 Million	-125,003 Reduced 54.1%	106,047 $2.22 Million
Q2 2021 Aug 11, 2021	SELL	$20.49 - $35.63 $1.66 Million - $2.88 Million	-80,885 Reduced 25.93%	231,050 $6.21 Million
Q1 2021 May 12, 2021	SELL	$18.99 - $33.2 $107,692 - $188,277	-5,671 Reduced 1.79%	311,935 $9.94 Million
Q4 2020 Feb 10, 2021	BUY	$19.41 - $26.0 $2.19 Million - $2.94 Million	112,988 Added 55.22%	317,606 $7.26 Million
Q3 2020 Nov 13, 2020	BUY	$24.69 - $31.6 $431,778 - $552,620	17,488 Added 9.35%	204,618 $5.15 Million
Q2 2020 Aug 12, 2020	BUY	$5.2 - $29.12 $421,980 - $2.36 Million	81,150 Added 76.57%	187,130 $5.23 Million
Q1 2020 May 14, 2020	SELL	$4.28 - $12.11 $1.02 Million - $2.88 Million	-237,676 Reduced 69.16%	105,980 $617,000
Q4 2019 Feb 12, 2020	BUY	$7.95 - $12.27 $793,839 - $1.23 Million	99,854 Added 40.96%	343,656 $3.74 Million
Q3 2019 Nov 12, 2019	SELL	$12.44 - $17.48 $706,405 - $992,601	-56,785 Reduced 18.89%	243,802 $3.11 Million
Q2 2019 Aug 09, 2019	BUY	$14.51 - $19.71 $4.36 Million - $5.92 Million	300,587 New	300,587 $5.1 Million

Others Institutions Holding MGNX

# of Institutions

130

Shares Held

56M

Call Options Held

28.3K

Put Options Held

197K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $173M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Macrogenics Inc Transaction History